AAAAAA

   
Results: 1-16 |
Results: 16
SAFETY OF ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY
Authors: ZAJECKA J FAWCETT J AMSTERDAM J QUITKIN F REIMHERR F ROSENBAUM J MICHELSON D BEASLEY C
Citation: J. Zajecka et al., SAFETY OF ABRUPT DISCONTINUATION OF FLUOXETINE - A RANDOMIZED, PLACEBO-CONTROLLED STUDY, Journal of clinical psychopharmacology, 18(3), 1998, pp. 193-197
OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT
Authors: REIMHERR FW AMSTERDAM JD QUITKIN FM ROSENBAUM JF FAVA M ZAJECKA J BEASLEY CM MICHELSON D ROBACK P SUNDELL K
Citation: Fw. Reimherr et al., OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT, The American journal of psychiatry, 155(9), 1998, pp. 1247-1253
DISCONTINUATION SYMPTOMS AFTER TREATMENT WITH SEROTONIN REUPTAKE INHIBITORS - A LITERATURE-REVIEW
Authors: ZAJECKA J TRACY KA MITCHELL S
Citation: J. Zajecka et al., DISCONTINUATION SYMPTOMS AFTER TREATMENT WITH SEROTONIN REUPTAKE INHIBITORS - A LITERATURE-REVIEW, The Journal of clinical psychiatry, 58(7), 1997, pp. 291-297
SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A HYPOTHETICAL DEFINITION
Authors: SCHATZBERG AF HADDAD P KAPLAN EM LEJOYEUX M ROSENBAUM JF YOUNG AH ZAJECKA J
Citation: Af. Schatzberg et al., SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A HYPOTHETICAL DEFINITION, The Journal of clinical psychiatry, 58, 1997, pp. 5-10
POSSIBLE BIOLOGICAL MECHANISMS OF THE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME
Authors: SCHATZBERG AF HADDAD P KAPLAN EM LEJOYEUX M ROSENBAUM JF YOUNG AH ZAJECKA J
Citation: Af. Schatzberg et al., POSSIBLE BIOLOGICAL MECHANISMS OF THE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME, The Journal of clinical psychiatry, 58, 1997, pp. 23-27
CLINICAL MANAGEMENT OF ANTIDEPRESSANT DISCONTINUATION
Authors: ROSENBAUM JF ZAJECKA J
Citation: Jf. Rosenbaum et J. Zajecka, CLINICAL MANAGEMENT OF ANTIDEPRESSANT DISCONTINUATION, The Journal of clinical psychiatry, 58, 1997, pp. 37-40
IMPORTANCE OF ESTABLISHING THE DIAGNOSIS OF PERSISTENT ANXIETY
Authors: ZAJECKA J",YONKERS,SMALL,LYDIARD,LIEBERMAN
Citation: Zajecka J",yonkers,small,lydiard,lieberman, IMPORTANCE OF ESTABLISHING THE DIAGNOSIS OF PERSISTENT ANXIETY, The Journal of clinical psychiatry, 58, 1997, pp. 9-15
TREATMENT-EMERGENT CHANGES IN SEXUAL FUNCTION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS AS MEASURED WITH THE RUSH SEXUAL INVENTORY
Authors: ZAJECKA J MITCHELL S FAWCETT J
Citation: J. Zajecka et al., TREATMENT-EMERGENT CHANGES IN SEXUAL FUNCTION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS AS MEASURED WITH THE RUSH SEXUAL INVENTORY, Psychopharmacology bulletin, 33(4), 1997, pp. 755-760
BUSPIRONE AUGMENTATION OF NEFAZODONE IN DEPRESSION
Authors: BARBEE J ZAJECKA J KORNSTEIN S BORIAN FE HAMID S JODY DN
Citation: J. Barbee et al., BUSPIRONE AUGMENTATION OF NEFAZODONE IN DEPRESSION, Psychopharmacology bulletin, 33(3), 1997, pp. 494-494
AN OPEN-LABEL STUDY OF NEFAZODONE IN GENERAL PSYCHIATRIC PRACTICES - TREATMENT OF DEPRESSION WITH A FOCUS ON ANXIETY, SLEEP, AND SEXUAL FUNCTION
Authors: FAWCETT J ZAJECKA J REIMHERR F KORNSTEIN S BORIAN FE IENI JR JODY DN
Citation: J. Fawcett et al., AN OPEN-LABEL STUDY OF NEFAZODONE IN GENERAL PSYCHIATRIC PRACTICES - TREATMENT OF DEPRESSION WITH A FOCUS ON ANXIETY, SLEEP, AND SEXUAL FUNCTION, Psychopharmacology bulletin, 33(3), 1997, pp. 521-521
MEASURING THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON SEXUAL FUNCTION USING THE RUSH SEXUAL INVENTORY
Authors: MITCHELL S ZAJECKA J
Citation: S. Mitchell et J. Zajecka, MEASURING THE EFFECT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS ON SEXUAL FUNCTION USING THE RUSH SEXUAL INVENTORY, Psychopharmacology bulletin, 33(3), 1997, pp. 558-558
NATIONAL COLLABORATIVE STUDY OF NEFAZODONE AND CBT-CD IN CHRONICALLY DEPRESSED-PATIENTS
Authors: RUSH AJ KELLER MB ZAJECKA J TRIVEDI M NINAN P NEMEROFF C
Citation: Aj. Rush et al., NATIONAL COLLABORATIVE STUDY OF NEFAZODONE AND CBT-CD IN CHRONICALLY DEPRESSED-PATIENTS, Biological psychiatry, 41, 1997, pp. 317-317
AN OPEN-LABEL STUDY OF MIRTAZAPINE IN DEPRESSED-PATIENTS WHO FAILED TREATMENT WITH AN SSRI
Authors: FAVA M DUNNER D GREIST J HORNIGROHAN M PRESKORN S TRIVEDI M ZAJECKA J COHEN M WINGARD P
Citation: M. Fava et al., AN OPEN-LABEL STUDY OF MIRTAZAPINE IN DEPRESSED-PATIENTS WHO FAILED TREATMENT WITH AN SSRI, Biological psychiatry, 41, 1997, pp. 330-330
IMPROVEMENT IN SUBJECTIVE WORK PERFORMANCE AFTER TREATMENT OF CHRONICDEPRESSION - SOME PRELIMINARY-RESULTS
Authors: FINKELSTEIN SN BERNDT ER GREENBERG PE PARSLEY RA RUSSELL JM KELLER MB GELENBERG A DELGADO P DEAN J STEWARD J BOLOGNA L JOYCE P CARMAN JS FEIGHNER JP MCNEAL C HENDRICKSON G FAWCETT J ZAJECKA J JEFFRIES H RUSH AJ TRAPP G HOLDEN M HIRSCHFELD RMA RUSSELL J TALBOT K SCOTT R KOCSIS JH MARKOWITZ J FRIEDMAN R CAPPOLINO C GNIEWESCH L MILLER N THASE ME HOWLAND R MCGREARY J STUPAR L HOGARTY S KEITNER G HOWARD D CROOKS S SHEA MT PATO MT COHEN S TODDLINGLEY L SCHATZBERG AF KORAN L JACOB M COX K BREEN JA KLEIN DN KLEIN L",HENN,SCHALGER,"MCCULLOUGH JP KORNSTEIN S BURKE L
Citation: Sn. Finkelstein et al., IMPROVEMENT IN SUBJECTIVE WORK PERFORMANCE AFTER TREATMENT OF CHRONICDEPRESSION - SOME PRELIMINARY-RESULTS, Psychopharmacology bulletin, 32(1), 1996, pp. 33-40
PANIC DISORDER AND POSTTRAUMATIC-STRESS-DISORDER
Authors: ZAJECKA J
Citation: J. Zajecka, PANIC DISORDER AND POSTTRAUMATIC-STRESS-DISORDER, Psychiatric annals, 26(7), 1996, pp. 480-487
LATENCY TO RAPID EYE-MOVEMENT SLEEP AS A PREDICTOR OF TREATMENT RESPONSE TO FLUOXETINE AND PLACEBO IN NONPSYCHOTIC DEPRESSED OUTPATIENTS
Authors: HEILIGENSTEIN JH FARIES DE RUSH AJ ANDERSEN JS PANDE AC ROFFWARG HP DUNNER D GILLIN JC JAMES SP LAHMEYER H ZAJECKA J TOLLEFSON GD GARDNER DM
Citation: Jh. Heiligenstein et al., LATENCY TO RAPID EYE-MOVEMENT SLEEP AS A PREDICTOR OF TREATMENT RESPONSE TO FLUOXETINE AND PLACEBO IN NONPSYCHOTIC DEPRESSED OUTPATIENTS, Psychiatry research, 52(3), 1994, pp. 327-339
Risultati: 1-16 |